期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
基因治疗:过去、现在和未来 被引量:1
1
作者 刘国庆 徐一童 冼勋德 《中国医药导刊》 2023年第1期9-12,共4页
基因治疗最初的概念是将包含正常基因的DNA序列通过载体导入细胞内以矫正由于该基因缺陷所导致的疾病。由于这个概念非常直观且易于接受,而临床上众多基因缺陷导致的遗传性疾病基本无药可治,因此基因治疗产生伊始便受到了高度关注。随... 基因治疗最初的概念是将包含正常基因的DNA序列通过载体导入细胞内以矫正由于该基因缺陷所导致的疾病。由于这个概念非常直观且易于接受,而临床上众多基因缺陷导致的遗传性疾病基本无药可治,因此基因治疗产生伊始便受到了高度关注。随着20世纪七八十年代以来基因工程技术的长足发展,基因治疗从实验室研究进入了临床探索,并于1990年完成了第一个基因治疗的临床试验,进入了一个高速发展期。10年后由于美国的一项基因治疗临床试验发生了患者的意外死亡,全球的基因治疗研究明显放缓。基因治疗的重新兴起以美国食品药品管理局(FDA)批准的治疗Leber先天性黑朦的Luxturna(2017)和用于治疗脊髓性肌萎缩症(SMA)的Zolgensma(2019)上市为标志,疗效确切、价格昂贵的基因药物终于成为临床医生手中能够为以往束手无策的患者解除病痛的有力武器。而除了基因替代性基因补充疗法,针对临床不同需求的基因编辑性基因矫正疗法、基于反义寡核苷酸和小干扰RNA的基因抑制疗法、基于基因开关的基因调控疗法等多种基因治疗方法均在综合研发中。为促进我国基因治疗的发展,本研究概述了基因治疗的发展过程和近年来的发展现状,并展望了基因治疗未来的发展。 展开更多
关键词 基因治疗 基因补充疗法 基因抑制疗法 基因调控疗法
下载PDF
肝癌基因治疗策略 被引量:1
2
作者 钱学敏 李继强 《临床肝胆病杂志》 CAS 北大核心 2002年第6期327-329,共3页
关键词 基因疗法 自杀基因疗法 抑制基因疗法 免疫基因疗法 抗肿瘤血管生长 肝癌
下载PDF
Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs 被引量:11
3
作者 YiSHI DeHuaYANG JieXIONG JieJIA BingHUANG YouXinJIN 《Cell Research》 SCIE CAS CSCD 2005年第3期193-200,共8页
RNA interference (RNAi) is triggered by the presence of a double-stranded RNA (dsRNA), and results in the silencing of homologous gene expression through the specific degradation of an mRNA containing the same sequenc... RNA interference (RNAi) is triggered by the presence of a double-stranded RNA (dsRNA), and results in the silencing of homologous gene expression through the specific degradation of an mRNA containing the same sequence. dsRNAmediated RNAi can be used in a wide variety of eucaryotes to induce the sequence-specific inhibition of gene expression.Synthetic 21-23 nucleotide (nt) small interfering RNA (siRNA) with 2 nt 3' overhangs was recently found to mediate efficient sequence-specific mRNA degradation in mammalian cells. Here, we studied the effects of synthetic siRNA duplexes targeted to SARS coronavirus structural proteins E, M, and N in a cell culture system. Among total 26 siRNA duplexes, we obtained 3 siRNA duplexes which could sequence-specifically reduce target genes expression over 80% at the concentration of 60 nM in Vero E6 cells. The downregulation effect was in correlation with the concentrations of the siRNA duplexes in a range of 0~60 nM. Our results also showed that many inactive siRNA duplexes may be brought to life simply by unpairing the 5' end of the antisense strands. Results suggest that siRNA is capable of inhibiting SARS coronavirus genes expression and thus may be a new therapeutic strategy for treatment of SARS. 展开更多
关键词 SARS small interfering RNA Vero E6 cells EGFP fusion protein antiviral therapy.
下载PDF
Inhibitory effect of adenoviral vector-mediated AT2R gene transfection on neointimal hyperplasia
4
作者 唐兵 何国祥 +2 位作者 李德 黎军 姜大春 《Journal of Medical Colleges of PLA(China)》 CAS 2007年第1期23-27,共5页
Objective: To investigate the effect of adenoviral vector-mediated AT2R gene transfection on neointimal hyperplasia after rat carotid artery balloon injury. Methods :AT2R gene was transferred into rat carotid arteries... Objective: To investigate the effect of adenoviral vector-mediated AT2R gene transfection on neointimal hyperplasia after rat carotid artery balloon injury. Methods :AT2R gene was transferred into rat carotid arteries by recombinant adenovirus pAd-AT2R after the establishment of rat carotid balloon injury restenosis model. The arteries were harvested on the 14th day after gene transfer. The efficiency of trans-gene delivery was measured by the expression of adenovirus-encoding green fluorescent protein (GFP) under fluorescent microscope. The expression of AT2R and PCNA (proliferating cell nuclear antigen) was e-valuated by RT-PCR, immunocytochemistry, immunofluorescence staining, confocal microscopy, respectively. The ratio of intimal to medial area (I/M) was quantified with images and determined by an image analysis system. Results: GFP-positive area in adventitia, media and the forming neointima was about 40%. Adenoviral delivery of rat AT2R gene up-regulated AT2R expression in balloon-injured rat carotid and reduced PCNA expression and I/M significantly in neointima(P<0. 01). Double immunofluorescence labeling of AT2R and PCNA also showed that AT2R gene transfer inhibited VSMCs proliferation in neointima. Conclusion: AT2R gene transfer may be a novel promising therapy to limit neointimal hyperplasia. 展开更多
关键词 angiotensin RECEPTOR gene therapy RESTENOSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部